University of California San Francisco UCSF Medical CenterUCSF Department of SurgeryUCSF School of Medicine

FOLLOW

Surgery Websites
  • About Us

  • People

  • Research

  • Publications

  • Open Positions

  • Contact Us

  • News & Events

Kratz Lab »  Research
  • Thoracic Oncology Lab
  • Thoracic Oncology Program

Principal Investigator

Principal Investigator

Johannes R. Kratz, M.D.
Assistant Professor of Surgery
Van Auken Endowed Chair in Thoracic Oncology

Support the Research

Support the Research

A gift to the Kratz Lab will support the discovery of novel targets and personalized therapies for patients with surgical thoracic malignancies, such as lung, esophageal, and thymic cancer. 

Make a Gift »

We are Hiring!

We are Hiring!

We have open positions. Join our team of outstanding researchers. 

Learn more and apply
level

Research

Investigating Genetic and Immunological Mechanisms Driving Early-Stage, Surgically Resectable Thoracic Malignancies

Low Hig Intermediate RiskThe lab is investigating both the genetic as well as the immunological landscapes of early-stage high-risk tumors. Using the latest DNA / RNA sequencing and gene expression techniques combined with a bioinformatics-driven systems biology approach, the lab is comparing the different features of low- vs. high-risk early-stage lung cancer in order to gain a better understanding of the genetic nature of high-risk stage I lung cancer. The lab also utilizes cutting-edge immunological profiling techniques to investigate immune responses generated by certain patients that nurture high-risk disease. 

We are focusing on early-stage thoracic malignancies for three reasons.

  1. Early- stage tumors are high-yield research subjects as they are more homogenous and less complex than late-stage tumors.
  2. Patients with early-stage but high-risk disease are more likely to be cured by targeted interventions than patients with regional or metastatic late-stage disease.
  3. Despite their deadly nature, very few clinician-scientists target early-stage thoracic malignancies. Most interventions and clinical trials are designed for patients with late-stage disease, leaving a very large underserved population of patients with early-stage, yet deadly disease.

Identifying Genetic and Immunological Targets for Novel Interventions in High Risk Early Stage Lung Cancer

Shu Liu Phd And Computational ChemistryThe lab will leverage new new research discoveries to identify potential genetic and immunological targets of novel interventions such as biomarker-directed therapies, novel drugs and new immune-based therapies. Identification of these biomarkers and targets will allow the delivery of post-surgical interventions that patients with high-risk early-stage thoracic malignancies urgently need.

 
     
    Site Directory
    • Department of Surgery
    • Web Support Portal
    • Surgery Staff Portal
    • CLINICAL WEBSITES
    • Acute Care Surgery
    • Adult Cardiothoracic Surgery
    • Bariatric Surgery
    • Breast Care Surgery
    • Cardiac Surgery
    • Center for Hernia Repair & Abdominal Wall Reconstruction
    • Center for Limb Preservation and Diabetic Foot
    • Center for Surgery in Older Adults
    • Colorectal Surgery
    • Endocrine Surgery
    • Enhanced Recovery After Surgery (ERAS)
    • Fetal Treatment Center
    • Gastrointestinal Surgery
    • General Surgery
    • Hepatobiliary & Pancreatic Surgery
    • LiverSource
    • Melanoma Surgery
    • Ostomy Education Portal
    • Pediatric Cardiothoracic Surgery
    • Pediatric Surgery
    • Plastic & Reconstructive Surgery
    • Robotic Surgery
    • San Francisco VA Medical Center
    • Surgical Oncology Program
    • Thoracic Oncology Program
    • Thoracic Surgery
    • Transplant Surgery
    • UCSF East Bay Surgery Program
    • Vascular & Endovascular Surgery
    • Zuckerberg San Francisco General
    • EDUCATION AND TRAINING
    • Abdominal Transplant Fellowship
    • Faculty Affairs & Development Portal
    • Medical Student Portal
    • Muriel Steele Society
    • Plastic Surgery Residency
    • Resident Portal
    • Resident Research
    • Surgical & Critical Care NP Fellowship
    • Surgery Education Portal
    • Surgery Research Portal
    • Surgical Skills Center
    • Thoracic Surgery Residency
    • T32 Surgical Oncology
    • T32 Research Training in Transplant Surgery
    • UCSF-East Bay General Surgery Residency
    • Vascular Surgery Integrated Residency
    • RESEARCH WEBSITES
    • Atherosclerosis Research Lab
    • Biostatistics Core
    • Cardiothoracic Translational Research Lab
    • Cardiac Biomechanics Lab
    • Center for Global Surgery and Health Equity
    • Center for Maternal-Fetal Precision Medicine
    • Center for Mindfulness in Surgery
    • Chang Laboratory for Liver Tissue Engineering
    • Conte Lab
    • Endocrine Neoplasia Research Lab
    • Immunogenetics & Transplantation Lab
    • Kornblith Lab
    • Kratz Lab
    • Lobular Breast Cancer Research Program
    • MacKenzie Lab
    • Nijagal Lab
    • Pediatric Device Consortium
    • Pediatric Surgery Lab
    • Pomerantz Lab
    • San Francisco Wraparound Project
    • Sarwal Lab
    • Surgical Innovations
    • Warren Lab in Surgical Oncology
    • Tang Lab
    • Thoracic Oncology Lab
    • Transplantation Research Lab
    • TSI Lab
    • Wang Lab
    • Weaver Lab
    • Willenbring Lab
    • RESOURCES
    • Scientific Publications Office
      © 2023 The Regents of the University of California. 
      Terms of Use | Report a Problem
      Site Developer: Jason Powers; Web Manager, Rob Mayfield; Engineer, Digital Strategies

      FOLLOW

      X